United Laboratories International Holdings Ltd
HKEX:3933
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
United Laboratories International Holdings Ltd
Net Income (Common)
United Laboratories International Holdings Ltd
Net Income (Common) Peer Comparison
1177
HCM
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
32%
|
CAGR 10-Years
53%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Net Income (Common)
HK$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
34%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Net Income (Common)
¥2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
11%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
21%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Net Income (Common)
HK$3.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Net Income (Common)
$100.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
See Also
What is United Laboratories International Holdings Ltd's Net Income (Common)?
Net Income (Common)
2.7B
CNY
Based on the financial report for Dec 31, 2023, United Laboratories International Holdings Ltd's Net Income (Common) amounts to 2.7B CNY.
What is United Laboratories International Holdings Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
53%
Over the last year, the Net Income (Common) growth was 71%. The average annual Net Income (Common) growth rates for United Laboratories International Holdings Ltd have been 57% over the past three years , 32% over the past five years , and 53% over the past ten years .
You don't have any saved screeners yet
